Delivery Order SPE2DB20D3103-SPE2DB25FL7T1

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,257.30 firm fixed-price delivery order is for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication, with an ultimate completion date of December 3, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,066.13 firm fixed-price delivery order is for the supply of 4566964431 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with an ultimate completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $10,545.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Valsartan-HCTZ 320-25 mg tablets. The contract is not designated as a set-aside and has an ultimate completion date of June 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. The $5,218.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on September 4, 2024, with a completion date of September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a type of cardiovascular medication. The contract has a ceiling value of $18,847.33 and is a firm fixed price Delivery Order that runs through March 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,566.40 Firm Fixed Price delivery order contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The award has an ultimate completion date of October 31, 2024 and was made on October 30, 2024. There was no set-aside designation for this contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,220.05, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has a firm fixed price structure and a period of performance ending on May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,340.78 firm fixed-price delivery order contract is for the supply of 4567996134 - Valsartan-HCTZ 160-25 mg tablets. The contract has an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,546.25 firm-fixed-price delivery order is for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of February 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,770.57 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract does not have a set-aside designation and has a completion date of June 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL7T1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S. The $8,953.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 12:21 PM